STING1 and neoplasm: Recent studies demonstrate that activation of the stimulator of interferon genes (STING) pathway plays an essential role in initiating anti-tumor immunity through activation of antigen presenting cells (APCs), production of type I interferon and subsequent T cell priming and tumor-specific T- cell-responses.